DNM1L and Alzheimer disease: Taken together, our study showed that exogenous expression of Drp1 could promote crawling ability, reduced the level of ATP in Drosophila brain and suppressed neuronal degeneration, suggesting that Drp1 may be a potential therapeutic strategy for AD disease.